GlassScriptPhysician profile
Emilie Jacobsen
NPI 1548729445
$1,089.38
in general payments reported to CMS, 2019-2025
11 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $383 · 2024: $224 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.39 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $467.50 | 2023-2025 | |
| Lilly USA, LLC | $123.94 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $122.17 | 2023-2025 | Tremfya, Simponi, Stelara |
| Regeneron Healthcare Solutions, INC. | $100.94 | 2025 | Dupixent |
| Genzyme Corporation | $98.25 | 2023 | |
| Incyte Corporation | $59.62 | 2024-2025 | Opzelura |
| Amgen INC. | $41.90 | 2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $26.93 | 2025 | |
| Sun Pharmaceutical Industries INC. | $18.92 | 2023 | Ilumya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.80 | 2024 | Cabtreo |
| Kerecis Limited | $12.41 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilie Jacobsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.